Clinical Products

Controlling the healthcare environment with accurate, reliable active air sampling and evaluating its effectiveness are essential to protect your patients.

The choice of microbiologists worldwide for its ease-of-use and high-performance, the API^® ID strip range is the global reference for identification. API^® Strips are supported by APIWEB™ for anytime, anywhere identification. 

Real-time PCR assays for use on open platforms. 

Our real-time PCR assays permit rapid and speci­fic detection of various viral infections prior to viral diseases. This is of vital importance in the management of the transplant patients, to prevent rejection and to allow patient survival.

ARGENE^® Respiratory includes ready-to-use real-time PCR detection kits for viral respiratory diseases.

BACT/ALERT^® 3D brings flexible and modular automated detection systems for any size laboratory that needs to meet blood culture guidelines efficiently, economically, and effectively.

BACT/ALERT^® culture media offers a comprehensive range of media bottles to ensure the recovery of a wide variety of microorganisms including bacteria, mycobacteria, and fungi – including our next generation Fastidious Antimicrobial Neutralization Plus media (FAN^® PLUS) offering optimized time to detection and recovery. 

The first fully automated blood culture system, helping to refine and redesign laboratory workflow to maximize efficiency, while providing the fastest clinically impactful results on the market.^1,2

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

Providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE^® System performance, utilization, pathogen surveillance, workflow management, and more. 

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

The BIOFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for both respiratory or sore throat pathogens on the same panel, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.

The BIOFIRE^® SPOTFIRE^® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.

Creating a global surveillance network that displays BIOFIRE^® Panel test results from participating laboratories and hospitals around the world, BIOFIRE TREND allows users to explore epidemiology insights and better understand site-specific and regional pathogen trends and seasonality.